Response and Resistance to BCR-ABL1-Targeted Therapies

Published 2020 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Response and Resistance to BCR-ABL1-Targeted Therapies
Authors
Keywords
CML, tyrosine kinase inhibitor, targeted therapy, BCR-ABL
Journal
CANCER CELL
Volume 37, Issue 4, Pages 530-542
Publisher
Elsevier BV
Online
2020-04-13
DOI
10.1016/j.ccell.2020.03.006

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.